Condition
Carotid Arteriosclerosis clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Carotid Arteriosclerosis clinical trials that are recruiting, at sites in 5 countries (most in United States (1), Italy (1), Belgium (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 5Countries
Newest Carotid Arteriosclerosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Predicting unstable carotid plaques using radiomics and biomechanics | — | Milan | Recruiting | Oct 16, 2026 |
| Using IMPROVE to guide carotid revascularisation decisions | — | Arnhem, Gelderland and 9 other locations | Recruiting | Apr 29, 2026 |
| How menopause and HIV together affect cardiovascular disease risk in women. | — | San Francisco, California | Recruiting | Dec 16, 2025 |
| PET/MRI with [18F]AlF-NOTA-octreotide to image inflammation in carotid artery plaque | Phase 2 | Leuven, Vlaams-Brabant | Recruiting | Aug 5, 2025 |
| Residual and recurrent carotid narrowing after endarterectomy with primary closure | — | Prague | Recruiting | Jul 9, 2025 |
All recruiting trials (5)
-
Predicting unstable carotid plaques using radiomics and biomechanics
This study tests a noninvasive model to identify unstable carotid plaques in adults at initial diagnosis who may be candidates for carotid surgery.
-
Using IMPROVE to guide carotid revascularisation decisions
This trial tests whether using the IMPROVE MRI-based score to select patients for carotid revascularisation is as good as standard care based mainly on stenosis degree, among people who have had a recent stroke or TIA due to carotid disease.
-
How menopause and HIV together affect cardiovascular disease risk in women.
This study will see if menopause combined with HIV raises heart disease risk in women with HIV by examining risk factors, inflammation, body composition, and whole-body MRI.
-
PET/MRI with [18F]AlF-NOTA-octreotide to image inflammation in carotid artery plaque
This will test whether [18F]AlF-OC PET/MRI can measure inflammation in carotid plaques and help predict recurrent stroke or TIA in people who recently had a carotid-territory stroke or high-risk TIA with at least 30% carotid stenosis.
-
Residual and recurrent carotid narrowing after endarterectomy with primary closure
The study will test how often and when carotid narrowing comes back after elective carotid endarterectomy with primary closure in adults.
Related topics
Quick answers
How many Carotid Arteriosclerosis clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (1 trial), Italy (1 trial), Belgium (1 trial), Netherlands (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.